Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dezocine Injection IV PCA vs IV Bolus for Postoperative Moderate Pain
CTR20171319Phase 3Active
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dezocine in postoperative pain, sponsored by Yangtze River Pharmaceutical Group. Started Dec 2017; status: active.
02
Drugs
dezocine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20171319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171319.